5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts.
Vilma DembitzHrvoje LalicIvan KodvanjBarbara TomicJosip BatinicKlara DubravcicDrago BatinicAntonio BedalovDora VisnjicPublished in: BMC cancer (2020)
AICAr induces differentiation in a subset of primary non-APL AML blasts, and these effects correlate with sensitivity to a well-known, potent DHODH inhibitor.